readthroughSign in
CompanyBIOANasdaqEmeryville, CA

BioAge Labs, Inc.

BioAge is a clinical-stage biopharmaceutical company developing small-molecule NLRP3 and APJ agonist inhibitors for cardiometabolic diseases and inflammation-driven conditions including diabetic macular edema and obesity.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story